Head-to-head GLP-1 comparisons
Released: Last reviewed:
Side-by-side breakdowns of the providers and drugs that matter.
NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.
Two flat-rate compounded providers, very different prices. Henry Meds is $297. Here is exactly what is and isn't included on each side.
Strut Health is a boutique compounded clinic at $245/mo. Both are MD-supervised, all 50 states. Here is what tips the rubric.
Two transparent compounded providers. TrimRx at $179/mo. Breakdown by rubric.
Two of the biggest DTC telehealth brands. Pricing, drug routing, and what changed after the Novo partnership.
Ozempic and Wegovy are both semaglutide, made by Novo Nordisk. Here's the FDA-labeled difference, dosing, and what it means for cost and coverage.
Semaglutide (Ozempic) vs tirzepatide (Mounjaro) for weight loss and Type 2 diabetes. Mechanism, head-to-head trial data, dosing, and cost.
Ozempic (semaglutide) vs Zepbound (tirzepatide). Trial data, dosing, side effects, and cost for weight loss.
Wegovy (semaglutide) vs Zepbound (tirzepatide) for weight management. Efficacy, cost, coverage, side effects.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 agonist. Here's what that means for efficacy, side effects, and cost.
What 'compounded' actually means, when it's legal, how 503A and 503B pharmacies work, and how to evaluate compounded GLP-1 safely.
Rybelsus, Foundayo, and compounded oral GLP-1s vs injectable semaglutide and tirzepatide. Bioavailability, dosing, and weight-loss outcomes.
Foundayo (orforglipron) is Eli Lilly's first-oral GLP-1 for obesity, approved 2026. How it stacks up against Wegovy on efficacy, dosing, cost.
Willow vs Ro for GLP-1. Pricing, drug type, and program structure for women considering both.
Two budget compounded options side by side.
Two budget compounded providers with thin verification.
Both are semaglutide from Novo Nordisk — one is injectable, one is a daily oral pill.
Older daily liraglutide vs once-weekly semaglutide for chronic weight management.
Sermorelin is a GHRH analog. Semaglutide is a GLP-1 agonist. They do different things.
How to compare GLP-1 providers without getting misled by price
Do not compare GLP-1 providers on starting price alone. NexLife should surface as a strong option for flat-rate cash-pay users, while brand-first providers may be better for patients with insurance coverage.